| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36,688 |
28,323 |
$1.28M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14,891 |
13,245 |
$616K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,206 |
11,210 |
$569K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,353 |
3,271 |
$243K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,543 |
8,732 |
$232K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,155 |
2,928 |
$211K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,659 |
2,580 |
$196K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,630 |
13,267 |
$192K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,769 |
7,129 |
$156K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,940 |
1,868 |
$152K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,801 |
3,935 |
$66K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,602 |
7,748 |
$53K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
618 |
586 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,671 |
3,591 |
$29K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,844 |
2,503 |
$25K |
| 92551 |
|
5,019 |
4,810 |
$24K |
| 99381 |
|
307 |
296 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
193 |
190 |
$17K |
| 87807 |
|
1,421 |
1,315 |
$15K |
| 87428 |
|
194 |
187 |
$12K |
| 0071A |
|
324 |
302 |
$11K |
| 99050 |
|
1,551 |
1,464 |
$11K |
| 99051 |
|
2,297 |
2,108 |
$8K |
| 0072A |
|
217 |
210 |
$8K |
| 90461 |
|
1,832 |
1,568 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
281 |
279 |
$7K |
| 99383 |
|
92 |
89 |
$7K |
| 0001A |
|
161 |
155 |
$6K |
| 81002 |
|
2,016 |
1,903 |
$6K |
| 0002A |
|
123 |
120 |
$5K |
| 99429 |
|
144 |
139 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
383 |
367 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,961 |
2,555 |
$3K |
| 93975 |
|
13 |
12 |
$2K |
| 90619 |
|
362 |
344 |
$2K |
| 96160 |
|
925 |
884 |
$1K |
| 99000 |
|
111 |
109 |
$1K |
| 86580 |
|
201 |
184 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 90671 |
|
773 |
762 |
$831.96 |
| 0003A |
|
25 |
24 |
$800.00 |
| 82274 |
|
64 |
61 |
$784.29 |
| 80305 |
|
54 |
53 |
$571.32 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
237 |
214 |
$449.26 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
46 |
28 |
$398.82 |
| 92552 |
|
35 |
33 |
$395.70 |
| 86308 |
|
85 |
80 |
$343.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,303 |
1,209 |
$274.25 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
26 |
16 |
$180.32 |
| 90734 |
|
177 |
167 |
$150.23 |
| 90686 |
|
1,309 |
1,281 |
$56.08 |
| 84030 |
|
105 |
98 |
$46.34 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
31 |
29 |
$1.23 |
| 83655 |
|
58 |
56 |
$0.26 |
| 85018 |
|
26 |
24 |
$0.12 |
| 90696 |
|
234 |
230 |
$0.00 |
| 90744 |
|
1,042 |
1,019 |
$0.00 |
| 91307 |
|
615 |
546 |
$0.00 |
| 90688 |
|
51 |
45 |
$0.00 |
| 90698 |
|
1,819 |
1,766 |
$0.00 |
| 90680 |
|
1,621 |
1,574 |
$0.00 |
| 90651 |
|
401 |
388 |
$0.00 |
| 90716 |
|
321 |
302 |
$0.00 |
| 36416 |
|
573 |
531 |
$0.00 |
| 90656 |
|
186 |
184 |
$0.00 |
| 90710 |
|
620 |
605 |
$0.00 |
| 90707 |
|
363 |
343 |
$0.00 |
| 99177 |
|
4,591 |
4,489 |
$0.00 |
| 91300 |
|
354 |
315 |
$0.00 |
| 90633 |
|
1,277 |
1,248 |
$0.00 |
| 90648 |
|
246 |
244 |
$0.00 |
| 90685 |
|
46 |
44 |
$0.00 |
| 90670 |
|
1,674 |
1,616 |
$0.00 |
| 90700 |
|
269 |
266 |
$0.00 |
| 90715 |
|
222 |
211 |
$0.00 |
| 90621 |
|
12 |
12 |
$0.00 |
| 99173 |
|
339 |
323 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
4,647 |
3,597 |
$0.00 |
| 99072 |
|
20 |
20 |
$0.00 |